氯硝柳胺：一种已确立的抗蠕虫药物，作为针对S100A4介导的转移性结肠肿瘤的潜在疗法。 - Suppr

Suppr

超能文献

Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.

作者信息

Helfman David M

出版信息

J Natl Cancer Inst. 2011 Jul 6;103(13):991-2. doi: 10.1093/jnci/djr221. Epub 2011 Jun 17.

DOI:10.1093/jnci/djr221

PMID:21685360

Abstract

摘要

相似文献

Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.

J Natl Cancer Inst. 2011 Jul 6;103(13):991-2. doi: 10.1093/jnci/djr221. Epub 2011 Jun 17.

Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.

J Natl Cancer Inst. 2011 Jul 6;103(13):1018-36. doi: 10.1093/jnci/djr190. Epub 2011 Jun 17.

Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.

Neoplasia. 2011 Feb;13(2):131-44. doi: 10.1593/neo.101172.

S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.

Mol Biol Cell. 2011 Sep;22(18):3344-54. doi: 10.1091/mbc.E10-09-0739. Epub 2011 Jul 27.

The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.

Gastroenterology. 2006 Nov;131(5):1486-500. doi: 10.1053/j.gastro.2006.08.041. Epub 2006 Aug 22.

Wnt up your mind - intervention strategies for S100A4-induced metastasis in colon cancer.

Gen Physiol Biophys. 2009;28 Spec No Focus:F55-64.

Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.

BMC Cancer. 2010 Jun 1;10:250. doi: 10.1186/1471-2407-10-250.

The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.

Curr Cancer Drug Targets. 2015;15(8):726-38. doi: 10.2174/1568009615666150629132157.

Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.

Cancer Res. 2011 Jun 15;71(12):4172-82. doi: 10.1158/0008-5472.CAN-10-3978. Epub 2011 Apr 29.

S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.

Dis Esophagus. 2012 Nov-Dec;25(8):731-9. doi: 10.1111/j.1442-2050.2012.01323.x. Epub 2012 Mar 27.

引用本文的文献

MSI2 mediates WNT/β-Catenin pathway function in hematopoietic stem cells.

Leukemia. 2025 Jan;39(1):265-270. doi: 10.1038/s41375-024-02447-9. Epub 2024 Oct 22.

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Biomedicines. 2023 Apr 11;11(4):1152. doi: 10.3390/biomedicines11041152.

Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells.

Oncotarget. 2022 May 5;13:642-658. doi: 10.18632/oncotarget.28227. eCollection 2022.

S100A4+ macrophages facilitate zika virus invasion and persistence in the seminiferous tubules via interferon-gamma mediation.

PLoS Pathog. 2020 Dec 14;16(12):e1009019. doi: 10.1371/journal.ppat.1009019. eCollection 2020 Dec.

The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis.

Cells. 2019 Oct 16;8(10):1261. doi: 10.3390/cells8101261.

Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers.

Nat Commun. 2018 Sep 26;9(1):3931. doi: 10.1038/s41467-018-05805-1.

Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.

Int J Mol Sci. 2018 May 20;19(5):1524. doi: 10.3390/ijms19051524.

S100A4 in cancer progression and metastasis: A systematic review.

Oncotarget. 2017 May 19;8(42):73219-73239. doi: 10.18632/oncotarget.18016. eCollection 2017 Sep 22.

Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.

PLoS One. 2017 Sep 6;12(9):e0184324. doi: 10.1371/journal.pone.0184324. eCollection 2017.

S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction.

Cancers (Basel). 2016 Jun 20;8(6):59. doi: 10.3390/cancers8060059.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验